Literature DB >> 19076059

QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium.

Simonetta Genovesi1, Daniela M Prata Pizzala, Massimo Pozzi, Laura Ratti, Maria Milanese, Federico Pieruzzi, Antonio Vincenti, Andrea Stella, Giuseppe Mancia, Marco Stramba-Badiale.   

Abstract

A prolongation of QT interval has been shown in patients with cirrhosis and it is considered as part of the definition of the so-called 'cirrhotic cardiomyopathy'. The aim of the present study was to assess the determinants of QT interval prolongation in cirrhotic patients. Forty-eight male patients with different stages of liver disease were divided into three subgroups according to the Child-Pugh classification. All patients underwent a 24-h ECG Holter recording. The 24-h mean of QT intervals corrected for heart rate (termed QTc) and the slope of the regression line QT/RR were calculated. HRV (heart rate variability), plasma calcium and potassium concentration and HVPG (hepatic venous pressure gradient) were measured. QTc was progressively prolonged from Child A to Child C patients (P=0.001). A significant correlation between QTc and HVPG was found (P=0.003). Patients with alcohol-related cirrhosis presented QTc prolongation more frequently than patients with post-viral cirrhosis (P<0.001). The QT/RR slope was steeper in subjects with alcoholic aetiology as compared with viral aetiology (P=0.02), suggesting that these patients have a further QTc prolongation when heart rate decreases. The plasma calcium concentration was inversely correlated with QTc (P<0.001). The presence of severe portal hypertension was associated with decreased HRV (P<0.001). Cirrhotic patients with a more severe disease, especially of alcoholic aetiology, who have greater HVPG and lower calcium plasma levels, have an altered ventricular repolarization and a reduced vagal activity to the heart, which may predispose to life-threatening arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19076059     DOI: 10.1042/CS20080325

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

1.  Pharmacokinetics of linagliptin in subjects with hepatic impairment.

Authors:  Ulrike Graefe-Mody; Peter Rose; Silke Retlich; Arne Ring; Lisa Waldhauser; Rodica Cinca; Hans-Juergen Woerle
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 2.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 4.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

5.  A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome.

Authors:  Shrihari A Anikhindi; Piyush Ranjan; Mandhir Kumar; Rajat Mohan
Journal:  J Clin Exp Hepatol       Date:  2021-11-15

6.  QT/RR curvatures in healthy subjects: sex differences and covariates.

Authors:  Marek Malik; Katerina Hnatkova; Donna Kowalski; James J Keirns; E Marcel van Gelderen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-25       Impact factor: 4.733

Review 7.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Shantanu Patil; Toni Anne De Venecia; Vincent M Figueredo
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

9.  Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations.

Authors:  Christian Trolle; Kristian H Mortensen; Lisbeth N Pedersen; Agnethe Berglund; Henrik K Jensen; Niels H Andersen; Claus H Gravholt
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  Alteration of the QT variability index in end-stage liver disease.

Authors:  In Young Huh; Eun Sun Park; Kang-Il Kim; A-Ran Lee; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2014-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.